Results 91 to 100 of about 82,297 (115)

Dose Adjustment of JAK Inhibitors for the Management of Moderate-to-Severe Atopic Dermatitis: A Single-Centre Retrospective Study. [PDF]

Medicina (Kaunas)
Falcidia C, D'Oria F, Foggi G, Facheris P, Bianco M, Ibba L, Narcisi A, Costanzo A, Gargiulo L.   +8 more
europepmc   +1 more source

Understanding Cardiovascular Events With JAK Inhibitors: Similarities and Differences of the Vascular Effects Between Different JAK Inhibitors on Endothelial Cells Exposed to Inflammatory Cytokines. [PDF]

ACR Open Rheumatol
Zavoriti A, Miossec P.
europepmc   +1 more source

From apremilast to JAK inhibitors-salvage treatment strategies for refractory palmoplantar pustulosis: case series. [PDF]

Front Med (Lausanne)
Pan Y, Jin D, Meng F, Zhang H, Tang J, Guo C, Li C, Ma J.   +7 more
europepmc   +1 more source

Mastering the Use of Systemic JAK Inhibitors for Atopic Dermatitis: A Dermatologist's Practical Guide. [PDF]

Am J Clin Dermatol
Jalili A, Labbouz S, Gooderham M, Ziv M, Dodiuk-Gad RP.   +4 more
europepmc   +1 more source

Oral JAK Inhibitors in Pediatric Generalized Vitiligo Resistant to Conventional Treatment: A Case Series. [PDF]

Pediatr Dermatol
Vidal González A, Escudero Tornero R, López Alcázar S, Maseda Pedrero R, Feito Rodríguez M, De Lucas Laguna R.   +5 more
europepmc   +1 more source

JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety. [PDF]

JGH Open
Qtaishat FA, AlKayyat A, Yasin JA, A Tamimi MA, Tarawneh J, AlDaher L, Abdallah S, Alghaniem MMA, Abunamoos A, Musa A, Ateiwi YA, Taha Y, Tamimi TA.   +12 more
europepmc   +1 more source

JAK inhibitors for the treatment of juvenile localized scleroderma: a case report and literature review. [PDF]

Pediatr Rheumatol Online J
Zheng R, Zou L, Li SC, Lu M.
europepmc   +1 more source

Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector function. [PDF]

Cell Death Dis
Onofrio LI, Abrate C, Strusberg I, Morales L, Ceschin DG, Montes CL, Stempin CC, Acosta Rodríguez E.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

JAK inhibitors for rheumatoid arthritis

Expert Opinion on Investigational Drugs, 2023
Satoshi Kubo, Yoshiya Tanaka, Shingo Nakayamada   +2 more
exaly